QuidelOrtho
QDEL
#6044
Rank
HK$8.96 B
Marketcap
HK$131.51
Share price
1.21%
Change (1 day)
-27.22%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.

EPS for QuidelOrtho (QDEL)

EPS in 2026 (TTM): -HK$139.00

According to QuidelOrtho's latest financial reports the company's current EPS (TTM) is -HK$139.74. In 2025 the company made an earnings per share (EPS) of -HK$130.65 an increase over its 2024 EPS that were of -HK$237.46.

EPS history for QuidelOrtho from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$139.006.4%
2025-HK$130.65-44.98%
2024-HK$237.4618825%
2023-HK$1.25-101.27%
2022HK$98.65-25.12%
2021HK$131.75-12.64%
2020HK$150.80980.34%
2019HK$13.96-10.1%
2018HK$15.53-960.87%
2017-HK$1.80
2015-HK$1.33-15%
2014-HK$1.57-190.91%
2013HK$1.7346.67%
2012HK$1.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
HK$142.88-202.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
HK$25.88-118.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
HK$40.70-129.12%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
HK$60.38-143.21%๐Ÿ‡บ๐Ÿ‡ธ USA
OraSure Technologies
OSUR
-HK$8.16-94.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
HK$7.61-105.44%๐Ÿ‡บ๐Ÿ‡ธ USA